SCHEMBL924324

SCHEMBL924324

Cc1n[nH]c(F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9126671 0.77
SCHEMBL21737680 0.74
SCHEMBL20844121 0.72
SCHEMBL27845754 0.72
SCHEMBL20844143 0.72
SCHEMBL17522837 0.72
SCHEMBL10962770 0.72
SCHEMBL20844107 0.69
SCHEMBL12732019 0.69 DYRK1A (0.33)
SCHEMBL16963814 0.69 DYRK1A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103553-A1 NEW PROCESS FOR THE SYNTHESIS OF 5-FLUORO-3- (DIFUOROMETHYL) -5-FLUORO-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE FREE ACID THEREOF Fujian Yongjing Technology Co., Ltd (CN) 2022-12-21 EP claimed
US-20220372000-A1 New Process for the Synthesis of 5-Fluoro-3-(Difuoromethyl)-5-Fluoro-1-Methyl-1H-Pyrazole-4-Carboxylic Acid Derivatives and the Free Acid Thereof Fujian Yongjing Technology Co.,Ltd (CN) 2022-11-24 US claimed
CN-114450269-A Novel method for synthesizing 5-fluoro-3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazole-4-carboxylic acid derivative and free acid thereof 福建永晶科技股份有限公司 2022-05-06 CN claimed
CN-120081788-A Pyrazole amide compound containing 2- (4-bromo-2- (trifluoromethyl) phenoxy) phenyl fragment and application thereof 安徽理工大学 2025-06-03 CN disclosed
CN-120091815-A T-type voltage-gated calcium channel enhancer 广泛研究所股份有限公司 2025-06-03 CN disclosed
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
US-12180226-B2 Spirotricycle RIPK1 inhibitors and methods of uses thereof MERCK SHARP & DOHME LLC (US) 2024-12-31 US disclosed
CN-116535357-B Arylamino benzamide derivative containing substituted pyrazole structure, preparation method and application 西北农林科技大学 2024-10-11 CN disclosed
EP-4423096-A1 SPIROTRICYCLE RIPK1 INHIBITORS AND METHODS OF USES THEREOF Merck Sharp & Dohme LLC (US) 2024-09-04 EP disclosed
CN-118488957-A Spirotricyclic RIPK1 inhibitors and methods of use thereof 默沙东有限责任公司 2024-08-13 CN disclosed
CN-117534616-B Synthesis method of 3-difluoromethyl-1, 5-disubstituted pyrazole compound 西北师范大学 2024-07-30 CN disclosed
WO-2012163905-A1 METHOD FOR PREPARING A FLUORINATED ORGANIC COMPOUND RHODIA OPERATIONS (FR) 2012-12-06 WO disclosed
EP-2215096-B1 COPPER-OXYGEN ADDUCT COMPLEXES UNIV GIESSEN JUSTUS LIEBIG (DE) 2012-09-19 EP disclosed
US-20120016127-A1 COPPER-OXYGEN ADDUCT COMPLEXES JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) 2012-01-19 US disclosed
US-20120016127-A1 COPPER-OXYGEN ADDUCT COMPLEXES JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) 2012-01-19 US disclosed
US-7875647-B2 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders GREEN CROSS CORPORATION (KR) 2011-01-25 US disclosed
EP-2097410-A1 HETEROARYL-PYRAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS Green Cross Corporation (KR) 2009-09-09 EP disclosed
WO-2009052809-A1 COPPER-OXYGEN ADDUCT COMPLEXES JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) 2009-04-30 WO disclosed
US-20080081812-A1 Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists GREEN CROSS CORPORATION (KR) 2008-04-03 US disclosed
WO-2008039023-A1 HETEROARYL-PYRAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS GREEN CROSS CORPORATION (KR) 2008-04-03 WO disclosed